NasdaqGS - Nasdaq Real Time Price USD
AnaptysBio, Inc. (ANAB)
At close: November 1 at 4:00 PM EDT
After hours: November 1 at 5:16 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-129,398.00
-120,800.00
-73,593.00
-45,920.00
-14,157.00
Investing Cash Flow
145,987.00
144,754.00
-394,845.00
38,835.00
94,475.00
Financing Cash Flow
20,026.00
-59,297.00
44,017.00
252,298.00
-879.00
End Cash Position
71,821.00
35,965.00
71,308.00
495,729.00
250,516.00
Interest Paid Supplemental Data
--
--
--
--
4.00
Capital Expenditure
-502.00
-807.00
-358.00
-1,366.00
-569.00
Issuance of Capital Stock
2,214.00
2,472.00
11,827.00
2,553.00
496.00
Repayment of Debt
--
--
--
--
-1,375.00
Repurchase of Capital Stock
--
-50,000.00
--
--
--
Free Cash Flow
-129,900.00
-121,607.00
-73,951.00
-47,286.00
-14,726.00
12/31/2020 - 1/26/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LXEO Lexeo Therapeutics, Inc.
7.93
+0.38%
TYRA Tyra Biosciences, Inc.
16.39
-1.74%
EPIX ESSA Pharma Inc.
1.4000
-73.08%
VERA Vera Therapeutics, Inc.
43.82
+8.52%
BPMC Blueprint Medicines Corporation
90.70
+3.65%
AKRO Akero Therapeutics, Inc.
32.33
+4.87%
PRTA Prothena Corporation plc
16.65
-2.06%
SAGE Sage Therapeutics, Inc.
6.05
-0.49%
CORT Corcept Therapeutics Incorporated
47.62
-2.76%
INSM Insmed Incorporated
68.32
+1.55%